Concourse Financial Group Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,257
Closed -$1.52M 1263
2024
Q4
$1.52M Buy
17,257
+648
+4% +$56.1K 0.09% 239
2024
Q3
$1.51M Sell
16,609
-307
-2% -$25.8K 0.09% 221
2024
Q2
$1.34M Sell
16,916
-3,735
-18% -$306K 0.08% 226
2024
Q1
$1.81M Buy
20,651
+319
+2% +$27.2K 0.12% 184
2023
Q4
$1.69M Sell
20,332
-1,585
-7% -$121K 0.12% 176
2023
Q3
$1.73M Buy
21,917
+1,543
+8% +$129K 0.13% 166
2023
Q2
$1.81M Buy
20,374
+3,301
+19% +$284K 0.14% 151
2023
Q1
$1.39M Buy
17,073
+219
+1% +$17.8K 0.11% 193
2022
Q4
$1.32M Buy
+16,854
New +$1.37M 0.11% 209
2022
Q3
Sell
-14,804
Closed -$1.33M 2185
2022
Q2
$1.34M Buy
14,804
+1,104
+8% +$112K 0.11% 193
2022
Q1
$1.53M Sell
13,700
-2,096
-13% -$221K 0.11% 181
2021
Q4
$1.64M Buy
15,796
+810
+5% +$93.8K 0.09% 219
2021
Q3
$1.89M Buy
14,986
+1,547
+12% +$200K 0.12% 168
2021
Q2
$1.68M Buy
13,439
+1,067
+9% +$134K 0.11% 180
2021
Q1
$1.47M Buy
12,372
+2,919
+31% +$342K 0.1% 177
2020
Q4
$1.11M Buy
9,453
+1,619
+21% +$178K 0.08% 210
2020
Q3
$819K Buy
7,834
+1,432
+22% +$144K 0.07% 232
2020
Q2
$591K Buy
6,402
+1,399
+28% +$134K 0.06% 267
2020
Q1
$454K Buy
5,003
+654
+15% +$69.6K 0.05% 266
2019
Q4
$496K Buy
4,349
+2,647
+156% +$290K 0.05% 287
2019
Q3
$186K Sell
1,702
-1,998
-54% -$208K 0.05% 308
2019
Q2
$360K Buy
3,700
+352
+11% +$32.1K 0.04% 327
2019
Q1
$304K Sell
3,348
-1,605
-32% -$144K 0.03% 367
2018
Q4
$453K Buy
4,953
+2,622
+112% +$245K 0.05% 263
2018
Q3
$231K Buy
+2,331
New +$216K 0.07% 254

Other funds holding MDT

Concourse Financial Group Securities's MDT Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Medtronic (MDT) in Q1 2025, closing a stake of 17,257 shares — an estimated $1.52M sold.

Concourse Financial Group Securities first reported a position in MDT in Q3 2018 and held it in 25 quarters. The position peaked at $1.89M in Q3 2021. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 17,257 Medtronic shares in Q1 2025, an estimated $1.52M.
  • Concourse Financial Group Securities first reported a position in Medtronic in Q3 2018 and held it in 25 quarters.
  • Concourse Financial Group Securities's Medtronic position peaked at $1.89M in Q3 2021.
  • 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.